We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Waystar Holding Corp
WAY
$5.53B
| $1.53M | ﹤0.01% |
+74,438
| New | +$1.57M |
2026 Q2
0 quarters
|
|
1977
Webull Corp
BULL
$3.05B
| $1.52M | ﹤0.01% |
232,957
+25,572
| +12% | +$166K |
2025 Q2
4 quarters
|
|
1978
Toronto Dominion Bank
TD
$203B
| $1.52M | ﹤0.01% |
12,500
-4,728
| -27% | -$517K |
2025 Q3
3 quarters
|
|
1979
Ball Corp
BALL
$17.1B
| $1.51M | ﹤0.01% |
+24,219
| New | +$1.42M |
2026 Q2
0 quarters
|
|
1980
Compass Minerals
CMP
$893M
| $1.51M | ﹤0.01% |
48,503
-31,745
| -40% | -$898K |
2024 Q3
7 quarters
|
|
1981
Guardian Pharmacy Services
GRDN
$2.5B
| $1.51M | ﹤0.01% |
35,996
-381,714
| -91% | -$14.8M |
2026 Q1
1 quarter
|
|
1982
Corvus Pharmaceuticals
CRVS
$886M
| $1.5M | ﹤0.01% |
100,474
-447,811
| -82% | -$6.21M |
2025 Q4
2 quarters
|
|
1983
Interparfums
IPAR
$3.69B
| $1.5M | ﹤0.01% |
13,406
+4,600
| +52% | +$434K |
2024 Q1
9 quarters
|
|
1984
Lyell Immunopharma
LYEL
$230M
| $1.49M | ﹤0.01% |
106,300
-42,216
| -28% | -$764K |
2025 Q4
2 quarters
|
|
1985
Fennec Pharmaceuticals
FENC
$353M
| $1.49M | ﹤0.01% |
+138,758
| New | +$1.13M |
2026 Q2
0 quarters
|
|
1986
WisdomTree Artificial Intelligence and Innovation Fund
WTAI
$573M
| $1.49M | ﹤0.01% |
+31,420
| New | +$1.24M |
2026 Q2
0 quarters
|
|
1987
Cohen & Steers
CNS
$3.65B
| $1.49M | ﹤0.01% |
19,577
+2,619
| +15% | +$185K |
2025 Q1
5 quarters
|
|
1988
Veeva Systems
VEEV
$52.3B
| $1.49M | ﹤0.01% |
8,399
-749,628
| -99% | -$124M |
2024 Q2
8 quarters
|
|
1989
vTv Therapeutics
VTVT
$101M
| $1.49M | ﹤0.01% |
39,560
+26,171
| +195% | +$908K |
2026 Q1
1 quarter
|
|
1990
Sunrun
RUN
$1.83B
| $1.48M | ﹤0.01% |
110,974
+62,687
| +130% | +$846K |
2026 Q1
1 quarter
|
|
1991
CALL
Walmart Inc
WMT
$951B
| $1.48M | ﹤0.01% |
13,100
-14,600
| -53% | -$1.81M |
2025 Q4
2 quarters
|
|
1992
Vine Hill Capital Investment Corp II
VHCP
| $1.47M | ﹤0.01% |
147,255
-1,704
| -1% | -$17K |
2026 Q1
1 quarter
|
|
1993
Prestige Consumer Healthcare
PBH
$2.26B
| $1.47M | ﹤0.01% |
31,011
-24,241
| -44% | -$1.25M |
2026 Q1
1 quarter
|
|
1994
Andersen Group
ANDG
$1.18B
| $1.47M | ﹤0.01% |
38,848
+25,126
| +183% | +$886K |
2025 Q4
2 quarters
|
|
1995
SB Financial Group
SBFG
$189M
| $1.46M | ﹤0.01% |
+57,913
| New | +$1.28M |
2026 Q2
0 quarters
|
|
1996
Coya Therapeutics
COYA
$92.4M
| $1.46M | ﹤0.01% |
249,793
+24,001
| +11% | +$111K |
2025 Q3
3 quarters
|
|
1997
Lennar Class A
LEN
$20.2B
| $1.46M | ﹤0.01% |
16,116
-13,316
| -45% | -$1.19M |
2019 Q2
28 quarters
|
|
1998
CALL
GE Aerospace
GE
$296B
| $1.46M | ﹤0.01% |
+3,900
| New | +$1.22M |
2026 Q2
0 quarters
|
|
1999
OneWater Marine
ONEW
$156M
| $1.45M | ﹤0.01% |
128,856
-131,267
| -50% | -$1.41M |
2024 Q3
7 quarters
|
|
2000
BayCom
BCML
$333M
| $1.45M | ﹤0.01% |
+44,021
| New | +$1.35M |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.